Polyomaviruses (PyVs) are small (40 – 45 nm diameter) nonenveloped circular DNA viruses, widespread in nature - various mammals, including humans, birds and fish are known to be infected. Due to their small genome, compact virion size, low pathogenicity to humans and ability to transform cells both in vitro and in vivo, Polyomaviridae family members (e.g. Simian virus 40, SV40) have been repeatedly used as models in studies related to the detection of DNA superspiralisation, cancer research and others. Furthermore, the major structural capsid protein VP1 of polyomaviruses can assemble into virus-like particles (VLPs) [1]. VLPs mimic the native virus and retain its immunogenicity and can transfer DNA. These properties are very important in studying viral mechanisms and is attractive in gene therapy and vaccine creation. While human polyomaviruses are relatively well studied, the information on other mammalian polyomaviruses is still lacking. Only 16 out of 117 species of polyomaviruses are currently known to infect rodents. Given that rodents are the largest group of mammals, this is a relatively small number of viruses found.
In this study, the VLPs of novel Rattus rattus polyomavirus 1 (RratPyV1) and Microtus arvalis polyomavirus 2 (MarPyV2) were synthesized in yeasts Saccharomyces cerevisiae. Both these viruses were discovered in our laboratory in 2020 while screening Microtus arvalis and Rattus rattus rodent samples for polyomaviruses. Recombinant VP1 plasmids with galactose-inducing promoter (pFX7-RratPyV1-VP1 and pFX7-MarPyV2-VP1) were transformed into S. cerevisiae and protein synthesis was induced by galactose. VLPs were purified from yeast cell biomass through ultracentrifugation in saccharose and CsCl density gradients. SDS-PAGE analysis showed RratPyV1 and MarPyV2 VP1 proteins are ~ 45 kDa. Purified particles were analysed by Electron Microscopy imaging and it revealed the possible size of the capsid (MarPyV2 ~ 53 nm; RratPyV1 ~ 51 nm). VP1 VLPs of RratPyV1 were tested as antigen in ELISA and reacted positively with rat blood serums. Thus, these particles will be a useful resource for further research on rodent polyomaviruses and their seroprevalence.